Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 40 Breast Neoplasms 12 Prostatic Neoplasms 11 Fallopian Tube Neoplasms 10 Pancreatic Neoplasms 7 Neoplasms 7 Endometrial Neoplasms 7 Glioblastoma 6 Neoplasm Metastasis 5 Carcinoma, Ovarian Epithelial 5 Triple Negative Breast Neoplasms 4 Lung Neoplasms 4 Glioma 4 Small Cell Lung Carcinoma 3 Mesothelioma 3 Cystadenocarcinoma, Serous 3 Cholangiocarcinoma 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1

Interventions

pembrolizumab 1 niraparib 1 durvalumab 1 cabozantinib 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urothelial Cancer × niraparib × Clear all

NCT03425201 2024-12-31

NICARAGUA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1/2 Completed

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡